407 related articles for article (PubMed ID: 9416896)
1. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.
Stambler BS; Wood MA; Ellenbogen KA
Circulation; 1997 Dec; 96(12):4298-306. PubMed ID: 9416896
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing.
Stambler BS; Wood MA; Ellenbogen KA
Am J Cardiol; 1996 May; 77(11):960-6. PubMed ID: 8644646
[TBL] [Abstract][Full Text] [Related]
3. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
Howard PA
Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
[TBL] [Abstract][Full Text] [Related]
4. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
Volgman AS; Carberry PA; Stambler B; Lewis WR; Dunn GH; Perry KT; Vanderlugt JT; Kowey PR
J Am Coll Cardiol; 1998 May; 31(6):1414-9. PubMed ID: 9581743
[TBL] [Abstract][Full Text] [Related]
5. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs when procainamide and ibutilide are delivered into the right atrium versus intravenously.
Vereckei A; Warman E; Mehra R; Zipes DP
J Cardiovasc Electrophysiol; 2001 Mar; 12(3):330-6. PubMed ID: 11291807
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
[TBL] [Abstract][Full Text] [Related]
8. Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide?
Varriale P; Sedighi A
Clin Cardiol; 2000 Apr; 23(4):265-8. PubMed ID: 10763074
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ibutilide for termination of atrial fibrillation and flutter.
Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT
Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275
[TBL] [Abstract][Full Text] [Related]
10. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravenous amiodarone and ibutilide on action potential duration and atrial conduction kinetics in patients with persistent atrial fibrillation.
Sasaki N; Watanabe I; Kogawa R; Sonoda K; Takahashi K; Okumura Y; Ohkubo K; Nakai T; Hirayama A
Int Heart J; 2014; 55(3):244-8. PubMed ID: 24806377
[TBL] [Abstract][Full Text] [Related]
12. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of ibutilide for chemical cardioversion of atrial fibrillation and atrial flutter in cancer patients.
Bickford CL; Agarwal R; Urbauer DL; Durand JB; Lenihan DJ
Am J Med Sci; 2014 Apr; 347(4):277-81. PubMed ID: 23588261
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group.
Nørgaard BL; Wachtell K; Christensen PD; Madsen B; Johansen JB; Christiansen EH; Graff O; Simonsen EH
Am Heart J; 1999 Jun; 137(6):1062-9. PubMed ID: 10347332
[TBL] [Abstract][Full Text] [Related]
16. Conversion of atrial flutter by ibutilide is associated with increased atrial cycle length variability.
Guo GB; Ellenbogen KA; Wood MA; Stambler BS
J Am Coll Cardiol; 1996 Apr; 27(5):1083-9. PubMed ID: 8609325
[TBL] [Abstract][Full Text] [Related]
17. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
Kafkas NV; Patsilinakos SP; Mertzanos GA; Papageorgiou KI; Chaveles JI; Dagadaki OK; Kelesidis KM
Int J Cardiol; 2007 Jun; 118(3):321-5. PubMed ID: 17049640
[TBL] [Abstract][Full Text] [Related]
18. Conversion of recent-onset atrial fibrillation or flutter with amiodarone after ibutilide has failed: a rapid, efficient, and safe algorithm.
Dilaveris P; Synetos A; Giannopoulos G; Gialafos E; Stefanadis C
Ann Noninvasive Electrocardiol; 2005 Jul; 10(3):382-6. PubMed ID: 16029392
[TBL] [Abstract][Full Text] [Related]
19. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
[TBL] [Abstract][Full Text] [Related]
20. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
Vos MA; Golitsyn SR; Stangl K; Ruda MY; Van Wijk LV; Harry JD; Perry KT; Touboul P; Steinbeck G; Wellens HJ
Heart; 1998 Jun; 79(6):568-75. PubMed ID: 10078083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]